Cargando…
S229: PROPHYLACTIC EFFICACY OF INTRATHECAL VERSUS INTRAVENOUS METHOTREXATE FOR CNS RELAPSE IN HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA: A PHASE III RANDOMIZED, CONTROLLED STUDY
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428468/ http://dx.doi.org/10.1097/01.HS9.0000967828.60026.bd |
| _version_ | 1785090476871778304 |
|---|---|
| author | Yahng, Seung-Ah Yhim, Ho-Young Kwak, Jae-Yong Shin, Ho-Jin Moon, Joon Ho Eom, Hyeon-Seok Kang, Ka-Won Park, Yong Kim, Min Kyoung Lee, Se Ryun Kim, Dae Sik Kim, Hyo Jung Yi, Jun Ho Do, Young Rok Kang, Hye Jin Lim, Sungnam Yang, Deok Hwan |
| author_facet | Yahng, Seung-Ah Yhim, Ho-Young Kwak, Jae-Yong Shin, Ho-Jin Moon, Joon Ho Eom, Hyeon-Seok Kang, Ka-Won Park, Yong Kim, Min Kyoung Lee, Se Ryun Kim, Dae Sik Kim, Hyo Jung Yi, Jun Ho Do, Young Rok Kang, Hye Jin Lim, Sungnam Yang, Deok Hwan |
| author_sort | Yahng, Seung-Ah |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428468 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104284682023-08-17 S229: PROPHYLACTIC EFFICACY OF INTRATHECAL VERSUS INTRAVENOUS METHOTREXATE FOR CNS RELAPSE IN HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA: A PHASE III RANDOMIZED, CONTROLLED STUDY Yahng, Seung-Ah Yhim, Ho-Young Kwak, Jae-Yong Shin, Ho-Jin Moon, Joon Ho Eom, Hyeon-Seok Kang, Ka-Won Park, Yong Kim, Min Kyoung Lee, Se Ryun Kim, Dae Sik Kim, Hyo Jung Yi, Jun Ho Do, Young Rok Kang, Hye Jin Lim, Sungnam Yang, Deok Hwan Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428468/ http://dx.doi.org/10.1097/01.HS9.0000967828.60026.bd Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Yahng, Seung-Ah Yhim, Ho-Young Kwak, Jae-Yong Shin, Ho-Jin Moon, Joon Ho Eom, Hyeon-Seok Kang, Ka-Won Park, Yong Kim, Min Kyoung Lee, Se Ryun Kim, Dae Sik Kim, Hyo Jung Yi, Jun Ho Do, Young Rok Kang, Hye Jin Lim, Sungnam Yang, Deok Hwan S229: PROPHYLACTIC EFFICACY OF INTRATHECAL VERSUS INTRAVENOUS METHOTREXATE FOR CNS RELAPSE IN HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA: A PHASE III RANDOMIZED, CONTROLLED STUDY |
| title | S229: PROPHYLACTIC EFFICACY OF INTRATHECAL VERSUS INTRAVENOUS METHOTREXATE FOR CNS RELAPSE IN HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA: A PHASE III RANDOMIZED, CONTROLLED STUDY |
| title_full | S229: PROPHYLACTIC EFFICACY OF INTRATHECAL VERSUS INTRAVENOUS METHOTREXATE FOR CNS RELAPSE IN HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA: A PHASE III RANDOMIZED, CONTROLLED STUDY |
| title_fullStr | S229: PROPHYLACTIC EFFICACY OF INTRATHECAL VERSUS INTRAVENOUS METHOTREXATE FOR CNS RELAPSE IN HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA: A PHASE III RANDOMIZED, CONTROLLED STUDY |
| title_full_unstemmed | S229: PROPHYLACTIC EFFICACY OF INTRATHECAL VERSUS INTRAVENOUS METHOTREXATE FOR CNS RELAPSE IN HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA: A PHASE III RANDOMIZED, CONTROLLED STUDY |
| title_short | S229: PROPHYLACTIC EFFICACY OF INTRATHECAL VERSUS INTRAVENOUS METHOTREXATE FOR CNS RELAPSE IN HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA: A PHASE III RANDOMIZED, CONTROLLED STUDY |
| title_sort | s229: prophylactic efficacy of intrathecal versus intravenous methotrexate for cns relapse in high-risk diffuse large b cell lymphoma: a phase iii randomized, controlled study |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428468/ http://dx.doi.org/10.1097/01.HS9.0000967828.60026.bd |
| work_keys_str_mv | AT yahngseungah s229prophylacticefficacyofintrathecalversusintravenousmethotrexateforcnsrelapseinhighriskdiffuselargebcelllymphomaaphaseiiirandomizedcontrolledstudy AT yhimhoyoung s229prophylacticefficacyofintrathecalversusintravenousmethotrexateforcnsrelapseinhighriskdiffuselargebcelllymphomaaphaseiiirandomizedcontrolledstudy AT kwakjaeyong s229prophylacticefficacyofintrathecalversusintravenousmethotrexateforcnsrelapseinhighriskdiffuselargebcelllymphomaaphaseiiirandomizedcontrolledstudy AT shinhojin s229prophylacticefficacyofintrathecalversusintravenousmethotrexateforcnsrelapseinhighriskdiffuselargebcelllymphomaaphaseiiirandomizedcontrolledstudy AT moonjoonho s229prophylacticefficacyofintrathecalversusintravenousmethotrexateforcnsrelapseinhighriskdiffuselargebcelllymphomaaphaseiiirandomizedcontrolledstudy AT eomhyeonseok s229prophylacticefficacyofintrathecalversusintravenousmethotrexateforcnsrelapseinhighriskdiffuselargebcelllymphomaaphaseiiirandomizedcontrolledstudy AT kangkawon s229prophylacticefficacyofintrathecalversusintravenousmethotrexateforcnsrelapseinhighriskdiffuselargebcelllymphomaaphaseiiirandomizedcontrolledstudy AT parkyong s229prophylacticefficacyofintrathecalversusintravenousmethotrexateforcnsrelapseinhighriskdiffuselargebcelllymphomaaphaseiiirandomizedcontrolledstudy AT kimminkyoung s229prophylacticefficacyofintrathecalversusintravenousmethotrexateforcnsrelapseinhighriskdiffuselargebcelllymphomaaphaseiiirandomizedcontrolledstudy AT leeseryun s229prophylacticefficacyofintrathecalversusintravenousmethotrexateforcnsrelapseinhighriskdiffuselargebcelllymphomaaphaseiiirandomizedcontrolledstudy AT kimdaesik s229prophylacticefficacyofintrathecalversusintravenousmethotrexateforcnsrelapseinhighriskdiffuselargebcelllymphomaaphaseiiirandomizedcontrolledstudy AT kimhyojung s229prophylacticefficacyofintrathecalversusintravenousmethotrexateforcnsrelapseinhighriskdiffuselargebcelllymphomaaphaseiiirandomizedcontrolledstudy AT yijunho s229prophylacticefficacyofintrathecalversusintravenousmethotrexateforcnsrelapseinhighriskdiffuselargebcelllymphomaaphaseiiirandomizedcontrolledstudy AT doyoungrok s229prophylacticefficacyofintrathecalversusintravenousmethotrexateforcnsrelapseinhighriskdiffuselargebcelllymphomaaphaseiiirandomizedcontrolledstudy AT kanghyejin s229prophylacticefficacyofintrathecalversusintravenousmethotrexateforcnsrelapseinhighriskdiffuselargebcelllymphomaaphaseiiirandomizedcontrolledstudy AT limsungnam s229prophylacticefficacyofintrathecalversusintravenousmethotrexateforcnsrelapseinhighriskdiffuselargebcelllymphomaaphaseiiirandomizedcontrolledstudy AT yangdeokhwan s229prophylacticefficacyofintrathecalversusintravenousmethotrexateforcnsrelapseinhighriskdiffuselargebcelllymphomaaphaseiiirandomizedcontrolledstudy |